CD8A and COVID-19: As CD8+ T cells were the most affected subset in our COVID‐19 cohort, we asked whether the CD4‐to‐CD8 T cell ratio or the neutrophil‐to‐CD8 T cell ratio could be used as a prognostic marker for COVID‐19 in‐ICU mortality.